Caribou Biosciences (CRBU) Short-term Investments (2021 - 2026)

Caribou Biosciences (CRBU) has reported Short-term Investments for 6 consecutive years, with $105.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Short-term Investments fell 41.04% year-over-year to $105.6 million; the TTM figure through Mar 2026 stood at $105.6 million (down 41.04% YoY), while the FY2025 annual figure was $127.0 million, down 34.29% from the prior year.
• Short-term Investments fell to $105.6 million in Q1 2026 per CRBU's latest filing, from $127.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $277.7 million in Q4 2023 and bottomed at $105.6 million in Q1 2026.
• Historically, Short-term Investments has averaged $192.9 million across 5 years, with a median of $193.2 million in 2024.
• Annual changes were most pronounced in 2023 — Short-term Investments soared 46.66% — and 2026, when it tumbled 41.04%.
• Caribou Biosciences' Short-term Investments stood at $189.3 million in 2022, then soared by 46.66% to $277.7 million in 2023, then plunged by 30.4% to $193.2 million in 2024, then plunged by 34.29% to $127.0 million in 2025, then decreased by 16.86% to $105.6 million in 2026.
• Business Quant data shows CRBU's Short-term Investments at $105.6 million in Q1 2026, $127.0 million in Q4 2025, and $136.1 million in Q3 2025.